HomeQuestion

How do you counsel patients on their risk of retinopathy or vision loss when starting GLP-1 R agonists for diabetes management?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you approach adjusting insulin pump settings in patients who have received intra-articular corticosteroid injections?

How would you advise medical oncologists who recommend checkpoint inhibitors for a patient with baseline type 1 diabetes?

For patients on peritoneal dialysis with type 2 diabetes mellitus, do you have a preferred long- acting insulin and time of insulin administration?

How would you manage a patient who presents with hair loss that began after they started a GLP-1 inhibitor?

Do GLP 1 R agonists provide similar cardioprotective benefits in patients with Type 2 diabetes mellitus and ESRD on dialysis?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.